Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
International Journal of Chronic Obstructive Pulmonary Disease
|
May 5, 2025
Different Properties of the Erector Spinae and Multifidus Muscles on Physical Performance in Patients With Chronic Obstructive Pulmonary Disease
Kyosuke Imashiro, Masanori Nakanishi, Yuta Minoshima, et al.
Scientific Reports
|
January 4, 2026
Integration of patient-reported outcomes and myokine profiling for the detection of physical inactivity in COPD: an exploratory multicentre study
Tasuku Yamamoto, Tsunahiko Hirano, Keiko Doi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 2, 2018
Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab
Koichi Sato, Hiroaki Akamatsu, Eriko Murakami, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 18, 2026
Docetaxel plus ramucirumab immediately after immunotherapy in advanced NSCLC: A phase II study (DRUN)
Yuhei Harutani, Hiroaki Akamatsu, Takeya Sugimoto, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
International Journal of Chronic Obstructive Pulmonary Disease
|
May 5, 2025
Different Properties of the Erector Spinae and Multifidus Muscles on Physical Performance in Patients With Chronic Obstructive Pulmonary Disease
Kyosuke Imashiro, Masanori Nakanishi, Yuta Minoshima, et al.
Scientific Reports
|
January 4, 2026
Integration of patient-reported outcomes and myokine profiling for the detection of physical inactivity in COPD: an exploratory multicentre study
Tasuku Yamamoto, Tsunahiko Hirano, Keiko Doi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 2, 2018
Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab
Koichi Sato, Hiroaki Akamatsu, Eriko Murakami, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 18, 2026
Docetaxel plus ramucirumab immediately after immunotherapy in advanced NSCLC: A phase II study (DRUN)
Yuhei Harutani, Hiroaki Akamatsu, Takeya Sugimoto, et al.
Page
of 2